Back to mobile site

aTyr Pharma, Inc. (ATYR) Tops Q4 EPS by 5c

March 13, 2025 4:23 PM EDT

aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q4 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK